Lu Lucy
- SEC CIK
- 0001542419
No open-market purchases or sales filed in the past year.
Current role at each company
- VERU Veru Inc.Directoras of May 6, 2026
- FBIO Fortress Biotech, Inc.Directoras of Jan 3, 2025
- ATXI Avenue Therapeutics, Inc.President, CEOas of Dec 20, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lu Lucy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FBIO Fortress Biotech, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Lu LucyDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +12.0K | $0.84 | +$10.1K | +9.9%133.4K after |
VERU Veru Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Lu LucyDirector | PPurchase | +4.80K | $6.78 | +$32.5K | +96.0%9.80K after |